Measuring levels of inflammation in patients with heart failure and how they relate to heart function and quality of life
Not Applicable
Completed
- Conditions
- Heart failureCirculatory System
- Registration Number
- ISRCTN15573532
- Lead Sponsor
- niversity of Dundee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 77
Inclusion Criteria
1. Adults (>18 years)
2. Diagnosis of heart failure (stage B or stage C)
3. Able to give informed consent
Exclusion Criteria
Unable or unwilling to give consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of SIK activity measured by blood test at baseline
- Secondary Outcome Measures
Name Time Method At baseline:<br>1. Other blood markers of inflammation (interleukins 1-beta, 6 and 10, C-reactive protein)<br>2. Quality of life measured by the Kansas City Cardiomyopathy Questionnaire<br>3. Left ventricular ejection fraction measured by echocardiography